Contact
    Start Publications Tailored Nucleic Acid Architectures at Gold Surfaces for ...
    ←  Publication Finder
    QSense

    Tailored Nucleic Acid Architectures at Gold Surfaces for Controlled Therapeutic Release

    Journal: Langmuir, Volume 38, FEB 8, page 1698–1704

    Authors: Mosley, Robert J.; Hart, Julia; Davis, Kadie L.; Wower, Jacek; Byrne, Mark E.

    Organizations: Rowan University; NSF [1757815]; Directorate For Engineering; Div Of Engineering Education and Centers [1757815] Funding Source: National Science Foundation

    Nucleic acids are versatile materials capable of forming smart nanocarriers with highly controllable therapeutic delivery. DNA-gated release is a mechanism by which DNA oligonucleotides physically block the release of encapsulated drugs from porous nanoparticles. We extend this mechanism to be used with drugs bound to the surface of DNA-capped gold nanoparticles (AuNPs). We investigated DNA monolayers of different thicknesses and hybridization states to determine how DNA surface architecture can affect the release of a template drug bound to the gold surface. DNA layers are investigated on the planar gold surface via quartz crystal microbalance with dissipation and on AuNPs via dynamic light scattering. The resultant layer architectures were studied for their effect on the release rate of drugs. We observed that varying DNA architectures on AuNPs result in different release rates of the drug. The rate of drug release can be slowed using either folded or randomly coiled DNA sequences, which act as a physical barrier to diffusion. DNA monolayers with upright orientation release drugs more quickly. When the longer single-stranded DNA is used, the drug release is slowed even further. However, even upright DNA layers provide a barrier to drug diffusion at longer sequence lengths. We hypothesize that it is the architecture of the DNA layer, influenced by the folded or upright orientation of individual DNA molecules, that affects the free diffusion of the drug away from the AuNP surface. This mechanism may improve the biological availability of many surface-bound drugs on solid, DNA-capped nanoparticles.
    View publication